JFIF,,&ExifII* 4 :HP(1*X2; eibEnvironmental portrait of Dr. Robert Fox on 2-6-25. Robert Fox, MD, is a Staff Neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic.. Dr. Fox’s current research interests focus on innovative MRI techniques to evaluate MS treatments and tissue recovery after injury, where he is principal investigator and co-investigator on grants funded by the NIH and National MS Society. He serves as an advisory committee member and principal site investigator for many clinical trials, including coordinating global principal investigator for a Phase III clinical trial of dimethyl fumarate in relapsing remitting multiple sclerosis (MS). Photos by Lisa DeJongCanonCanon EOS R5,,Adobe Photoshop Camera Raw 17.1 (Windows)2025:02:12 11:31:47Lisa DeJongThe Cleveland Clinic, Enterprise Creative Services, Marketing Division © 2025. All Rights Reserved. "'020231    121 2$4D5 V 2025:02:06 15:53:462025:02:06 15:53:46-05:00-04:00+00:00Ho@B"@BqU}_S252026002159UURF85mm F1.2 L USM1710000584(MHH          Adobed  s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjzm!1AQa"q2#BRbr3$4CS%cs5DT &6E'dtU7()󄔤euFVfvGWgw8HXhx9IYiy*:JZjz ?뼀b#Bj4[cj*78"lU12⨫b4ъa՘TUcR@튢?*u:G Udإbr;sf㎛o"B۶*QPULUoӊ~XmRqVؚb&<6:WoYfbߚUO@1TOA~[('lU<˶*$).)}TFmzT4;b@QE UFbbu~XR.*UnVN*$ت,.تb튩ݟኤ>\#⬋w/6ت6OLU6l_U4*OT)#I40n8Plb_@wU'??F*bMqVؕ[u%WT*4V\U+ծ*`8$]~x'6*q%늢tbhH⩒[nso)~1q>UesqVMa`1T)` b1r*IoXx1ӵ]u@PW+y+l16=aO-̐_HFp]g?.;uW(\%:\86Ƹx6-&EK[7sHg*ve%01_~sXb<]q>6yƊ}9ݒ`b*2'Zl~ت!nl:zlWPN*h.T#*qV*ԞfF*iQ*lƿRQ0%Q*J>**axʺ@bkn_#?LP!/GQr{$crѴ+HbX:\#eRBI >INZe'A%l1ȄQMj+*g'Fӡ˱Nue_**ж*\~V7UW4'oὕVQ-R@U>[v WYn*qVHY*Ah늷-p%I銥38ت&FORqTHSlUR!DP3{U,ToS ϰqV/XVm&ȤpI؇hthڌը/y gf[g )!Ny3MZO6(zze5@HEѭL߾e8Y ap?udѰt,UqR뺂@SbƊNتµW21T[Q¸'8,QA*ZGA|U-ԯBs`M1T()@b}U**_qTӞ*XqTU*<η`m@q"BP2Lc%=|lf6rHR ե`1cˎ[^[^mIWq(U PT&~["lfV($xu!'$uG {N9n2Hj y-|ۄGOl+EsYcӿ.\)s6XSJb$ZzEBĠ?e83!žLYTGDt?/lTMqTN*8V0J޿* U^)$jԻzWDy<\SGYf*P TRHSkfn1UjX~<⩬Q҃V Utgn?⨴JR~[gM'cQ_Hm`(ƛV|HPw jm]^LUE>Q8wꆏz}zV] b$tpL`8~cxh$B++8K|a6 bK'enLďr3p{u'wG̗K])E#qU+RVCqUjLU *k p4ʹcANfFծ?9&(?_*帡8Z_动]6늨C'#SxتcsP14C$$dR}*68˒Pt)ͩeU\-YS?(m0 ~U76*9*U\by>UWW1W?t1VUK+Ą&OHɡ$235N>h e~AimӐ4f@;i9]ZAg`ޅY͙0ZH68wc%k&@A#|VvWAOfRB0hȆzƝt{Y⠂ YNve9H4\opK z~,qTx0Nث J]2⩏: x-TlU>Azî*KX\o;UT Zq~i1U9x|u5>+RЋ5+ *u+ff1qwc6IypjGBZR68m@OeSYǜm.n67[ގޜFzntHHZa H|ɥ$p,w$=.(.5ѣ!_钥?JcaS#S̶+4}{(g`<Ǫ~Fi}l|eUl!.q @[/!^تUUjBqV1@:M1U_.?^*ʱU;_#F8V\m加pÃqUoe${b8 *mV\U 6*kr#`=0jKB/'qFGZb|E8'%^$Z9Wz?FH"w$T)O+Ў@Sx"{>7Upֱ5$Ƶ z]xmZƆq`h/QԒ~LA @|YJ0D5YE(Ӓn-yJ˅f`4d))-eW?51sf#}N(Fi=Ͳ=U.1Ud늶mcfY-7#+yjQ&p݊UbW~U UbbPb UsD U)푘 bR銡G7"Qcr_!&徵r?Ȍ5?7e#/ e wX"RBe䐯$ H]KC5ߥЩ_#ȥ>\Nq#VJ UtYpO۽*D?Hqg̱ )Ƈ,`y6]KWi * NhiS|'3Q,`)Bz Uk)r@yhxmK4?1B˴h"Pzgȋ`gZETJ3˓a'Nk$6ڗy}]=0( Ï2& +ӦXwA`Mmj=9śv)9.^b4,Pj`k{nA^̄7WxeꧯɢܡZ4W?ȴ$U5 NTGCkpibM '+U+moJmu8.9sӡVYģBK鮤튤7Ksp=U@VSQ`u8)ȴZU⪀bw|UZ3+£Jb6򇉈QֳCn+yd*FKy_gr9phrf4?t$j~>{+ܬ\E<~ٖAq(r(zlrkigٸ.Տu WVH*E4i#Q&wV0*]Ɲ=>ս9XFV! ~`ቩBQ6bG }y >< KDyI`jҙtT)Jqi^ ~CE8Я.,$I\,nFSP~2uu?/i,vM"9hUhzR>PBH?[% ^FRk*r1Uz]n0U@ICC_PROFILE0ADBEmntrRGB XYZ acspAPPLnone-ADBE cprt2desc0kwtptbkptrTRCgTRCbTRCrXYZgXYZbXYZtextCopyright 1999 Adobe Systems IncorporateddescAdobe RGB (1998)XYZ QXYZ curv3curv3curv3XYZ OXYZ 4,XYZ &1/Photoshop 3.08BIMZ%G@NEU_Belsole_5603910_Environmental Portrait of Dr. Robert Fox_02-@NEU_Belsole_5603910_Environmental Portrait of Dr. Robert Fox_02- Lisa DeJongLDJreleases on filephotosTomsichMSMultiple Sclerosis MS treatments Neurologistbrain neurology Mellen Centerneurological diseases720240328< 080655-0500>20250206? 155346+0000P Lisa DeJongtdThe Cleveland Clinic, Enterprise Creative Services, Marketing Division © 2025. All Rights Reserved.xEnvironmental portrait of Dr. Robert Fox on 2-6-25. Robert Fox, MD, is a Staff Neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic.. Dr. Fox’s current research interests focus on innovative MRI techniques to evaluate MS treatments and tissue recovery after injury, where he is principal investigator and co-investigator on grants funded by the NIH and National MS Society. He serves as an advisory committee member and principal site investigator for many clinical trials, including coordinating global principal investigator for a Phase III clinical trial of dimethyl fumarate in relapsing remitting multiple sclerosis (MS). Photos by Lisa DeJongz Lisa DeJongC    !'"#%%%),($+!$%$C   $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$"=!1"2AQaBq#$34RbCDS!1!A"2BQ ? RQ`b,"i9tJ:FLNr"vcln!?Ah+Mt fT?\Oq#S@z~_8:(!FIG,xaKOtgp]fZ]W 7ۄF8|.C7ܺ`3P2 ]FAqƽ.;n{+5R)Dg$'}psp KXh:yݹ%isB!hC^N[2$$n1r#3J#A0otA+Od1%v?r?TmɦH@_5mp~ZF&$VQ{ZђI9+sBJڭ4slpG.ˎJR$R8e=L?6CC 3hF0#)X$l7W H Nn5[5•G+a<H}%S^k>e˜.P}iy381O}W%g _U-9X;8}+8.nj^cm pɜi,;p~cU7_=(n a;|(a;xoU&UEe+'x'ȴLw]-,T<27 WmMi/@tpmwG.ϦcigVR SSDZABog ֓1$moHl`&L׹ĄKyk j$i 8MZN~fvʧҍgKY'*\ӿ;Ԏk$K[ m7^f Zy䉊s|1A4Ki:l:Glіyu L;;=lDX$^]VÖo<|IxRe?Vj|n=cuo *[qzt98Ak霪5b%"B8n }yWW7|jH"ڹq]ۺti 9e[?gъW@>D`e8{u(gVq޴}-P#V(YԷa3̅㵞KPIk5-#9iKX$$>8E ߴOnIid#^lﴫA;}s+xdwNVdycuda(td& ?jw-#U6`S O4cC%_-x쎦wBHe! 襉ڛ)lqʸ  NpM[xc4yZ.ѾNi: